Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test showdown: which marker best spots ventilator pneumonia?

NCT ID NCT07696897

Not yet recruiting Diagnosis Sponsor: Sohag University Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This study compares two blood tests—procalcitonin and serum zinc—to see which more accurately diagnoses ventilator-associated pneumonia (VAP) in adult ICU patients. VAP is a common and serious infection in people on breathing machines, and early diagnosis is difficult. The trial will measure how well each test identifies the infection in 84 patients, using standard diagnostic criteria as the reference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If one biomarker proves more accurate, it could lead to faster, more reliable diagnosis of ventilator-associated pneumonia in ICU patients.
What could go wrong
This is a small, single-center observational study. Results may not apply to all ICU populations, and neither biomarker may prove clearly superior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENTILATOR ACQUIRED PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pneumonia, Ventilator-Associated

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENTILATOR ACQUIRED PNEUMONIA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sohag University Hospital

    Sohag, Sohag Governorate, 82524, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.